Modulation of morphine-induced antinociception in acute and chronic opioid treatment by ibudilast

Anesthesiology

Volumn 111, Issue 6, 2009, Pages 1356-1364

  Lilius, Tuomas O ^a   Rauhala, Pekka V ^a   Kambur, Oleg ^a   Kalso, Eija A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IBUDILAST; MORPHINE; NARCOTIC ANALGESIC AGENT; PHOSPHODIESTERASE INHIBITOR; PYRIDINE DERIVATIVE;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG POTENTIATION; HOT PLATE TEST; LOCOMOTION; MALE; MORPHINE TOLERANCE; MOTOR COORDINATION; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; ANIMAL; BODY EQUILIBRIUM; DRUG EFFECT; DRUG TOLERANCE; MOTOR ACTIVITY; PAIN ASSESSMENT; REACTION TIME; REVIEW; SPRAGUE DAWLEY RAT;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG TOLERANCE; MALE; MORPHINE; MOTOR ACTIVITY; PAIN MEASUREMENT; PHOSPHODIESTERASE INHIBITORS; POSTURAL BALANCE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

EID: 73449112286     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181bdfa11     Document Type: Article

References (32)

1. Kalso E, Edwards JE, Moore RA, McQuay HJ: Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 2004; 112:372-380
2. Hoskin PJ: Opioids in context: Relieving the pain of cancer-The role of comprehensive cancer management. Palliat Med 2008; 22:303-309
3. McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D, American Pain Society: Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review. J Pain 2003; 4:231-256
4. Zuo Z: The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance. Anesth Analg 2005; 101:728-734
5. Shimoyama N, Shimoyama M, Davis AM, Monaghan DT, Inturrisi CE: An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance. J Pharmacol Exp Ther 2005; 312:834-840
6. Mao J, Sung B, Ji RR, Lim G: Chronic morphine induces downregulation of spinal glutamate transporters: Implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 2002; 22:8312-8323
7. Pasternak GW: When it comes to opiates, just say NO. J Clin Invest 2007; 117:3185-3187
8. Xie JY, Herman DS, Stiller C, Gardell LR, Ossipov MH, Lai J, Porreca F, Vanderah TW: Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 2005; 25:409-416
9. Song P, Zhao ZQ: The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001; 39:281-286
10. Raghavendra V, Tanga FY, DeLeo JA: Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 2004; 29:327-334
11. Milligan ED, Watkins LR: Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009; 10:23-36
12. Raghavendra V, Rutkowski MD, DeLeo JA: The role of spinal neuroim-mune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 2002; 22:9980-9989
13. Shavit Y, Wolf G, Goshen I, Livshits D, Yirmiya R: Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain 2005; 115:50-59
14. Mayer DJ, Mao J, Holt J, Price DD: Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 1999; 96:7731-7736
15. Raith K, Hochhaus G: Drugs used in the treatment of opioid tolerance and physical dependence: A review. Int J Clin Pharmacol Ther 2004; 42:191-203
16. Raghavendra V, Tanga F, Rutkowski MD, DeLeo JA: Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: Mechanistic implications of spinal glia and proinflammatory cytokines. Pain 2003; 104:655-664
17. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR: A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 2004; 24:7353-7365
18. Mizuno T, Kurotani T, Komatsu Y, Kawanokuchi J, Kato H, Mitsuma N, Suzumura A: Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 2004; 46:404-411
19. Suzumura A, Ito A, Yoshikawa M, Sawada M: Ibudilast suppresses TNFa production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS. Brain Res 1999; 837:203-212
20. Kawanokuchi J, Mizuno T, Kato H, Mitsuma N, Suzumura A: Effects of interferon-beta on microglial functions as inflammatory and antigen presenting cells in the central nervous system. Neuropharmacology 2004; 46:734-742
21. Ledeboer A, Liu T, ShumillaJA, MahoneyJH, Vijay S, Gross MI, Vargas JA, Sultzbaugh L, Claypool MD, Sanftner LM, Watkins LR, Johnson KW: The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. Neuron Glia Biol 2007; 2:279-291
22. Hutchinson MR, Lewis SS, Coats BD, Skyba DA, Crysdale NY, Berkelham-mer DL, Brzeski A, Northcutt A, Vietz CM, Judd CM, Maier SF, Watkins LR, Johnson KW: Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav Immun 2009; 23:240-250
23. Ledeboer A, Hutchinson MR, Watkins LR, Johnson KW: Ibudilast (AV-411): A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs 2007; 16:935-950
24. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16:109-110
25. Gardmark M, Hoglund AU, Hammarlund-Udenaes M: Aspects on tail-flick, hot-plate and electrical stimulation tests for morphine antinociception. Pharmacol Toxicol 1998; 83:252-258
26. Dennis SG, Melzack R, Gutman S, Boucher F: Pain modulation by adrenergic agents and morphine as measured by three pain tests. Life Sci 1980; 26:1247-1259 (Pubitemid 10080617)
27. Sharma SK, Klee WA, Nirenberg M: Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 1975; 72:3092-3096
28. Wang Z, Bilsky EJ, Porreca F, Sadee W: Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci 1994; 54:PL339-50
29. Montminy MR, Bilezikjian LM: Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 1987; 328:175-178
30. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, Nestler EJ: CREB (cAMP response element-binding protein) in the locus coeruleus: Biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 1997; 17:7890-7901
31. Cui Y, Chen Y, Zhi JL, Guo RX, Feng JQ, Chen PX: Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Res 2006; 1069:235-243
32. Liu W, Wang CH, Cui Y, Mo LQ, Zhi JL, Sun SN, Wang YL, Yu HM, Zhao CM, Feng JQ, Chen PX: Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia. Neurosci Lett 2006; 410:174-177